Benzinga | Nov 4, 2020 04:23PM EST

Harpoon Therapeutics Q3 EPS $(0.53) Up From $(0.65) YoY, Sales $3.89M Up From $1.42M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.53) per share. This is a 18.46 percent increase over losses of $(0.65) per share from the same period last year. The company reported $3.89 million in sales this quarter. This is a 174.74 percent increase over sales of $1.42 million the same period last year.